壳核
多巴胺转运体
纹状体
多巴胺能
多巴胺
帕金森病
心理学
内科学
左旋多巴
痴呆
腹侧纹状体
神经科学
内分泌学
医学
疾病
作者
Seok Jong Chung,Hye Sun Lee,Han Soo Yoo,Yang Hyun Lee,Phil Hyu Lee,Young H. Sohn
出处
期刊:Neurology
[Ovid Technologies (Wolters Kluwer)]
日期:2020-07-21
卷期号:95 (3)
被引量:31
标识
DOI:10.1212/wnl.0000000000009878
摘要
To investigate whether the patterns of striatal dopamine depletion on dopamine transporter (DAT) scans could provide information on the long-term prognosis in Parkinson disease (PD).We enrolled 205 drug-naive patients with early-stage PD, who underwent 18F-FP-CIT PET scans at initial assessment and received PD medications for 3 or more years. After quantifying the DAT availability in each striatal subregion, factor analysis was conducted to simplify the identification of striatal dopamine depletion patterns and to yield 4 striatal subregion factors. We assessed the effect of these factors on the development of levodopa-induced dyskinesia (LID), wearing-off, freezing of gait (FOG), and dementia during the follow-up period (6.84 ± 1.80 years).The 4 factors indicated which striatal subregions were relatively preserved: factor 1 (caudate), factor 2 (more-affected sensorimotor striatum), factor 3 (less-affected sensorimotor striatum), and factor 4 (anterior putamen). Cox regression analyses using the composite scores of these striatal subregion factors as covariates demonstrated that selective dopamine depletion in the sensorimotor striatum was associated with a higher risk for developing LID. Selective dopamine loss in the putamen, particularly in the anterior putamen, was associated with early development of wearing-off. Selective involvement of the anterior putamen was associated with a higher risk for dementia conversion. However, the patterns of striatal dopamine depletion did not affect the risk of FOG.These findings suggested that the patterns of striatal dopaminergic denervation, which were estimated by the equation derived from the factor analysis, have a prognostic implication in patients with early-stage PD.
科研通智能强力驱动
Strongly Powered by AbleSci AI